China vs EU MDR / IVDR
This page compares China's NMPA device regulation framework with the EU's MDR/IVDR requirements. Detailed comparison tables are being developed.
Why this comparison matters
Understanding how China's requirements differ from other major frameworks helps manufacturers:
- Identify data gaps early
- Sequence submissions efficiently
- Re-use clinical and technical data across markets
- Avoid surprises from China-unique requirements (e.g. China Agent, 5-year re-registration, clinical trial exemption list)
See also: Multi-Market Strategy
Disclaimer
Content on this site is written with AI assistance and is intended as a navigation aid only. Always verify against official NMPA sources before making regulatory decisions. Not affiliated with NMPA or any Chinese Government body. Not legal or regulatory advice.